A specific protein in nearly 100 percent of high-grade meningiomas - the most common form of brain tumor has been discovered by scientists. Importantly, the investigators say, the protein -- NY-ESO-1 -- is already at the center of a clinical trial underway at the National Cancer Institute. That trial is designed to activate the immune systems of patients with other types of tumors that express the protein, training the body to attack the cancer and eradicate ...Saturday 31 August 2013
New Therapeutic Target for Hard-to-treat Brain Tumor Identified
A specific protein in nearly 100 percent of high-grade meningiomas - the most common form of brain tumor has been discovered by scientists. Importantly, the investigators say, the protein -- NY-ESO-1 -- is already at the center of a clinical trial underway at the National Cancer Institute. That trial is designed to activate the immune systems of patients with other types of tumors that express the protein, training the body to attack the cancer and eradicate ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment